GLP-1 Stack: What It Means and What Is Safe (October 2026)

01 · The core answer

Should you build a GLP-1 stack? The honest answer

For most people the answer is no: you do not need a stack, and some stacks are unsafe. If you are considering weight-loss treatment, the decision is between one properly prescribed licensed medicine and nothing at all. It is not between a licensed medicine and a cocktail of extras.

The term stack comes from bodybuilding and peptide-wellness forums. There it means layering several compounds to chase a bigger effect. Medicine does not work like that. Every licensed treatment has been tested on its own, at set doses, in a defined population, with known side effects and a monitored supply chain. When you add a second active ingredient, you step outside everything that testing told us.

Mounjaro (tirzepatide) is the clearest example. It is a once-weekly injectable licensed in the UK for weight management in adults and for type 2 diabetes.¹ Its mechanism already covers GIP and GLP-1 receptors, so there is no gap that another GLP-1 product would fill. Layering on top of it adds risk without a proven benefit.

The two decisions you are actually facing

Decision one: is treatment relevant to me? Licensed weight-management medicines are for adults who meet clinical criteria, assessed by a prescriber. NICE recommends Mounjaro for adults with a BMI of at least 35 plus at least one weight-related condition.⁴ Your own situation may differ, which is why a prescriber reviews each person individually.

Decision two: what support is worth adding? The licensed approach is treatment alongside a reduced-calorie diet and increased physical activity.¹ Anything beyond that, such as a protein shake or a vitamin, is a discussion for your prescriber rather than something to improvise from social media.

If you are ready to look at the regulated route, you can see the Mounjaro pen, prices and consultation for the free online consultation. Your first 2.5mg pen costs £129.99 as a first-order price with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price. For wider background, our weight loss clinic hub explains the full pathway. If you use an oral contraceptive pill, Mounjaro can reduce how well it is absorbed: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.

02 · What stacking means

What people mean by a GLP-1 stack

A GLP-1 stack is an informal label for combining a GLP-1 receptor medicine with other products to try to improve results. The label has no clinical definition, and different websites use it for very different things.

In practice, the word covers four loose groups. The first is the core medicine itself, such as semaglutide or tirzepatide. The second is what wellness sellers call secondary peptides, which are unlicensed compounds marketed to protect muscle or boost fat loss. The third is supplements, meaning low-cost products sold as natural alternatives or add-ons. The fourth is nutritional support, such as protein-rich meals and shakes used when appetite is low.

These groups carry completely different levels of risk. Nutritional habits are everyday choices that you can discuss with your prescriber. Supplements are cheaply available without assessment, and their dosing is not standardised. Unlicensed peptides and duplicate GLP-1 medicines sit at the dangerous end, because nobody has tested them together with the licensed medicine.

Why the term spreads so quickly

Social media rewards bold claims. A post that says a combination is faster, stronger or smarter travels further than one that says to take a single licensed medicine as prescribed. Sellers of research peptides and so-called shred stacks benefit from that attention. If you want to see how these claims are discussed, our piece on shred stack reviews looks at the marketing, and our guide to the tirzepatide stack covers the same question for the active ingredient in Mounjaro.

A useful test

Ask three questions about any product in a so-called stack. Is it licensed in the UK for this purpose? Has it been tested together with the medicine you take? Is it supplied by a regulated pharmacy after a prescriber review? If the answer to any is no, it is not part of a safe plan. Mounjaro itself is a prescription-only medicine, supplied after an online consultation reviewed by a GPhC-registered prescriber, and it is used alongside a reduced-calorie diet and increased physical activity.¹

Wanting the best result from treatment is reasonable. The safest way to get it is to take the medicine as prescribed, keep your reviews and put effort into food and activity rather than into adding unproven products.

03 · Why combining is unsafe

Why combining GLP-1 medicines is not safe

Combining GLP-1 medicines is unsafe because no one has tested the combination. These combinations have no safety data and no regulated supply chain. If something promises faster results outside a licensed pathway, that is the warning sign.

The mechanism already covers the target

Tirzepatide activates the GIP and GLP-1 receptors. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. Because Mounjaro already acts on the GLP-1 pathway, adding semaglutide or liraglutide on top is duplication, not complementary action.

Because Mounjaro slows stomach emptying, combining it with other products can affect how quickly some oral medicines are absorbed. Stacking two products with the same effect has no safety data behind it.

Dose is already built in

Mounjaro is designed to be increased step by step through six strengths, from 2.5mg to 15mg, so that the dose can be tailored to the person.¹ Your prescriber decides when to move up, based on how you are responding and tolerating it. Adding another product to chase a bigger effect bypasses that careful sequence.

What the trials tested

The efficacy figures people quote come from trials of one medicine at defined doses alongside diet and exercise. In the SURMOUNT-1 trial, people took tirzepatide with lifestyle changes and were compared with lifestyle changes alone.² Those results say nothing about what happens when other compounds are added, so quoting them in support of a stack is misleading.

If you take other medicines for diabetes, tell your prescriber. Insulin and sulfonylureas may need dose adjustments because of the risk of low blood sugar. That is a supervised adjustment, not a reason to experiment.

04 · Research peptides and copies

Research peptides, compounded copies and counterfeit risk

When a seller names a compound such as retatrutide, remember that it has no UK licence, and we do not suggest anyone use it.¹

What no regulated supply chain means

With a licensed medicine, the pen comes from the manufacturer through authorised distribution, in the right strength, with a patient leaflet, batch information and cold-chain storage. With a research peptide or compounded copy, you rely on the seller's word. Many such sellers use dramatic weight-loss claims to attract buyers. Treat those claims as marketing, not evidence.

The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme for reporting suspected side effects and fake products.⁷ If you have bought something and feel unwell, speak to a healthcare professional and report it through Yellow Card. If you have severe, persistent stomach pain, pain in the upper right abdomen with fever or yellowing of the skin or eyes, or swelling of the face or throat and difficulty breathing, get medical help straight away.

How to spot a safe supplier

A legitimate UK online pharmacy appears on the GPhC register, requires a consultation reviewed by a prescriber, and dispenses a licensed product. You can check ours: EverydayMeds is a GPhC-registered pharmacy, registration 9012878, and you can look it up on the GPhC public register. Our Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens.

Warning signs include a seller offering to supply without a consultation or prescription, prices that look far too low, vague origin, no pharmacy registration number and promises of specific results. If a deal looks surprisingly cheap, ask what has been left out. Our guide on whether GLP-1 treatment is a con goes through how to separate genuine care from scams.

The same caution applies to unlicensed injectable products that call themselves a GLP-1 but are sold without prescriptions. The safest rule is plain: if it needs a prescription and the seller does not ask for a consultation, walk away.

05 · Supplements and natural claims

Supplements, "natural GLP-1" claims and appetite tablets

Supplements marketed as natural GLP-1 boosters are not licensed weight-loss medicines and cannot be treated as equivalent to them. They are low-cost supplements with no clinical oversight, and their dosing is not standardised. That is the honest summary of an area full of exaggeration.

Nature's Ozempic and similar labels

Phrases such as "nature's Ozempic" borrow the credibility of a licensed medicine for a product that has not been through the same testing. If a seller quotes dramatic results, ask what trial they come from, how long it ran and who was in it. Often there is no answer.

Boots Appetite Control Tablets and similar products

People often ask whether appetite-control tablets from high-street retailers work. If you are comparing, the useful questions are what the active ingredient is, what it is licensed for and whether anyone reviews your suitability. For a pharmacist's view on a particular product, ask your community pharmacy.

Our piece on GLP-1 technology explains the science of the licensed medicines, which helps to show how different that is from a supplement.

Why the price gap matters

Cost is the main attraction of supplements. But a lower cost is a framing point, not a reason to believe a product works. A licensed medicine reflects development, trials, quality controls and pharmacy oversight. For context on prescribed treatment, across the UK pharmacies we track (checked 10 October 2026), Mounjaro pens range from £143.96 to £339.00 per month depending on dose and provider. A supplement does not become a fair substitute because it costs less.

Is pramlintide a GLP-1?

Another common point of confusion is whether other injectable diabetes medicines belong in a stack. Our explainer on whether pramlintide is a GLP-1 sets out how that medicine differs. The general principle holds: do not add another medicine to your treatment unless your prescriber has chosen it for you.

If you notice a new symptom after starting any supplement, tell your prescriber and consider reporting it through the Yellow Card scheme.¹⁹

06 · What sensible support looks like

What sensible support alongside treatment looks like

Sensible support means the licensed foundation: a reduced-calorie diet, increased physical activity and regular reviews. Mounjaro is used alongside a reduced-calorie diet and increased physical activity, not instead of them.¹ The trial results say the same: treatment works alongside lifestyle changes, and individual results vary.²

Food

Many people find they feel fuller sooner and less hungry between meals, which makes a reduced-calorie diet easier to follow. That is also the moment to think about food quality, because smaller portions leave less room for nutrients. Build meals around foods that you tolerate well and that keep you satisfied. If you find eating hard, or you feel unwell after meals, tell your prescriber rather than trying to fix it with a product from the internet.

Meal replacements and shakes are a common part of what the internet calls a stack. They are an everyday food choice rather than a medicine, and whether one suits you is a question for your prescriber or a dietitian. If you prefer to make your own, our ideas for GLP-1 smoothies show how to plan simple, gentle drinks for days when appetite is low.

Activity

Increased physical activity is part of the licensed use. Build it gradually and choose something you will keep doing.

Reviews and tracking

Our service includes ongoing monthly clinical reviews, dose-titration and follow-up assessments by the prescribing team, and side-effect support. Repeat orders re-check suitability, and there is no auto-shipping. You can also use GLPTrackr, our free companion app for iOS and Android, to keep a record of doses, symptoms and progress so that review conversations are more productive.

The simplest way to get more from treatment is to attend reviews, report side effects early and stay consistent with food and activity. None of that needs a stack, and all of it is safe.

07 · Results, stopping and switching

Results, stopping treatment and switching medicines

Stopping a GLP-1 medicine means the drug leaves your system gradually. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ Plan any change with your prescriber rather than on your own.

What the trial shows

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, and individual results vary. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them. Trial averages do not predict your own result, and they say nothing about stacks.

Is Mounjaro the best GLP-1?

It is tempting to ask which medicine is strongest. The honest answer is that strength is not a single measure. Mounjaro activates both GIP and GLP-1 receptors, which distinguishes it from single-action medicines such as semaglutide.¹ SURMOUNT-5 was the first large head-to-head trial of tirzepatide and semaglutide for weight loss.¹⁵ The right medicine is the one a prescriber judges suitable for you.

Switching, not stacking

If your current medicine is not working for you, the answer is a prescriber-led switch, not adding a second product. Wegovy (semaglutide) is a once-weekly alternative whose pens run 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, stepping up after at least four weeks to the 2.4mg maintenance dose from week 17.¹⁸ You can see the Wegovy pen page, where your first order is £99.99 as a first-pen price. Liraglutide, by contrast, is a daily injection supplied at 6mg per millilitre.

Why people stop

Reasons for stopping vary from person to person and include side effects, cost and personal choice. If you are thinking of stopping, speak to your prescriber first. They can discuss tolerability, dose and what comes next.

08 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

09 · Cost, NHS and ordering

Cost, NHS access and how to order safely

Safe treatment can be reached through the NHS or a regulated private pharmacy. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

What private treatment costs

Each pen lasts four weeks. At standard prices, the 2.5mg starter pen is £169.99, 5mg is £218.99, 7.5mg is £279.99, 10mg is £290.99, 12.5mg is £319.99 and 15mg is £329.99. If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg. A new customer's first order is £40 less, with code FIRST40, and every later order is £25 less, with code DOSE25. Prices were checked 10 October 2026. All six doses are in stock.

Set that against the stack idea. A set of extra products adds cost without evidence, while the licensed medicine is the part that has been tested.

How ordering works

Ordering has four steps. First, a free online consultation, a short health questionnaire with no charge and no obligation. Second, a prescriber review by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Third, dispensing by our registered pharmacy, with same-day dispatch when ordered by 3pm. Fourth, free next-day tracked delivery by DPD in temperature-controlled, discreet packaging. Saturday delivery is £14.99.

Needles, a sharps bin and injection guidance come with every order. You can pay by Visa or Mastercard, Klarna or pay-monthly options, and there are no subscriptions. Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone.

Trusted by over 100,000 customers on their weight loss journey, we do not promise results, and the price shown is the price paid. To begin, go to the Mounjaro consultation. This page is information, not a substitute for medical advice.